Browsing: Weight Loss

The Oregon Health & Science University and Portland State University School of Public Health hosts an initiative to combat “anti-fat bias.”

As a Celebrity Reporter, I cover everything from fashion and award shows to TV, film, and cultural conversations

Muscle loss and nutrient deficiencies: India’s first GLP-1 guidance on the cost of weight loss – The South First | News, Politics, Sports, Entertainment & Live Updates ${author.name} `; }); } else { authorsHTML = `

Samsung Biologics (207940.KS) has made the largest investment in the history of Korean pharmaceutical and biotech mergers and acquisitions (M&A) to enter the peptide contract development and manufacturing organization (CDMO) business, aiming to secure a competitive edge in the global obesity treatment market, which is expected to grow to 200 trillion won over the next…

TRADEThis view shows avocados produced in Mexico displayed for sale at a Walmart store in Mexico City on October 27, 2025. (Photo by Yuri CORTEZ / AFP) (Photo by YURI CORTEZ/AFP

When I was 22, I took a job as a hostess at a hibachi restaurant in Huntington Village, the Long Island, New York, town I grew up in. Hostessing was lonely and boring, but I got free carrot ginger dressing that I’d scoop into small bowls from the vat in the kitchen and eat like…

Amgen Inc. (ISIN US0311621009) stock sits in the large-cap pharma bracket with investors closely watching how recent double-digit revenue growth and the integration of Horizon Therapeutics translate into future earnings power. In 2023 Amgen reported revenue of roughly $28.2 billion, up around 7% from about $26.3 billion in 2022, while the company continued to return…

PARIS—Horizon Health is expanding its commitment to comprehensive weight loss care with the addition of Medical Weight Management within its Center for Weight Management

To describe the impact of nutrient-stimulated hormone (NuSH) therapies on weight loss by bariatric surgery type, diabetes status, and timing of initial NuSH prescription

Novo Nordisk stock is trading close to record territory, supported by strong demand for its GLP-1 diabetes and obesity treatments and robust recent financial results. The Danish pharmaceutical group Novo Nordisk A/S (ISIN DK0062498333) has reported double digit revenue and operating profit growth in its latest full year and interim figures, underpinned by rapid uptake…